Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             92 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A bayesian approach to sample size determination in phase II cancer clinical trials Sylvester, Richard J.
1984
5 3 p. 305-
1 p.
artikel
2 A computerized inventory control system for the management of study drugs and devices Collins, Dorthea
1984
5 3 p. 309-310
2 p.
artikel
3 A covariate model for repeated binary responses Muenz, Larry R.
1984
5 3 p. 297-
1 p.
artikel
4 Adherence measures in the aspirin myocardial infarction study (AMIS) Verter, Joel
1984
5 3 p. 306-
1 p.
artikel
5 Analyses of morbidity with death as a competing risk Seigel, Daniel
1984
5 3 p. 297-
1 p.
artikel
6 An elegant new assay of drug-induced eye irritation Scoville, B.
1984
5 3 p. 296-297
2 p.
artikel
7 An evaluation of the data validation system in a multicenter clinical trial Jackson, Melvin R.
1984
5 3 p. 312-
1 p.
artikel
8 Angina scoring method in the VA CABG study Peduzzi, Peter
1984
5 3 p. 291-
1 p.
artikel
9 An interactive approach to sequential treatment assignment Lee, Jeannette Y.
1984
5 3 p. 295-
1 p.
artikel
10 An investigation of the validity of comparing noncurrent treatments Reading, James C.
1984
5 3 p. 308-
1 p.
artikel
11 Announcements 1984
5 3 p. 317-319
3 p.
artikel
12 A note on data monitoring, incomplete data and curtailed testing Pasternack, Bernard S.
1984
5 3 p. 217-222
6 p.
artikel
13 APL programs for outcome probabilities and confidence limits in sequential binomial trials Larsen, Severin Olesen
1984
5 3 p. 245-249
5 p.
artikel
14 A randomized clinical trial of brain resuscitation following cardiac arrest Kelsey, S.F.
1984
5 3 p. 292-
1 p.
artikel
15 Ascertainment system for morbidity and mortality follow-up of SHEP participants Harvey, S.
1984
5 3 p. 313-
1 p.
artikel
16 A simple ECG abnormality coding device applicable in multicenter trials Kerkkamp, H.J.J.
1984
5 3 p. 292-
1 p.
artikel
17 A survey of nursing roles in clinical trials Smith, Jacqueline
1984
5 3 p. 294-
1 p.
artikel
18 A system to check eligibility in a randomized clinical trial with complicated admission criteria Tijssen, J.G.P.
1984
5 3 p. 313-314
2 p.
artikel
19 Berkson's bias and simpson's paradox are the same fallacy in the analysis of cross-classified categorical data Terrin, Michael L.
1984
5 3 p. 301-
1 p.
artikel
20 Biased estimates of treatment effect in randomized trials Gail, Mitchell
1984
5 3 p. 303-
1 p.
artikel
21 Bias, Maximum likelihood estimators, and sequential clinical trials Dupont, William D.
1984
5 3 p. 275-277
3 p.
artikel
22 Branch vein occlusion study Mead, L.
1984
5 3 p. 292-293
2 p.
artikel
23 Cancer research campaign clinical trials centre—its contribution to improved clinical trial methodology Houghton, Joan
1984
5 3 p. 308-
1 p.
artikel
24 Changing the protocol: A case report from the macular photocoagulation study 1984
5 3 p. 203-216
14 p.
artikel
25 Clinical trial results: Impact on clinician Probstfield, Jeffrey L.
1984
5 3 p. 301-
1 p.
artikel
26 Clinical trials and medical practice: Methodological considerations Hasford, Joerg
1984
5 3 p. 300-
1 p.
artikel
27 Clinical trials and medical technologies assessment. The experience of the CEDIT Durieux, Pierre
1984
5 3 p. 300-
1 p.
artikel
28 Comparability of randomized groups Altman, Douglas G.
1984
5 3 p. 297-
1 p.
artikel
29 Competency-based survey method for assessing physician clinical trial knowledge and skills Russell, Michael L.
1984
5 3 p. 300-301
2 p.
artikel
30 Computer-assisted protocol monitoring in trials with complex treatment protocols: The SHEP study Fox, C.
1984
5 3 p. 304-
1 p.
artikel
31 Coordinator turnover in the macular photocoagulation study Optican, Donna C.
1984
5 3 p. 294-
1 p.
artikel
32 Cost-effective choice of accural and follow-up periods for clinical trials Morgan, Timothy M.
1984
5 3 p. 312-
1 p.
artikel
33 Current management questionnaires and protocol design Riley, Diana L.
1984
5 3 p. 309-
1 p.
artikel
34 Design considerations in randomized crossover trials Lubsen, J.
1984
5 3 p. 296-
1 p.
artikel
35 Design of a data entry package for clinical trials Aus, Berit Marie
1984
5 3 p. 311-
1 p.
artikel
36 Development of methodology to aid participation in colorectal cancer marker study Lennon, Christina A.
1984
5 3 p. 309-
1 p.
artikel
37 Distributed data processing as a clinical management tool in collaborative trials: The SHEP study Remijas, T.
1984
5 3 p. 313-
1 p.
artikel
38 Effects of cholestyramine treatment on progression of coronary atherosclerosis: The NHLBI type II coronary intervention study Kelsey, S.F.
1984
5 3 p. 292-
1 p.
artikel
39 Estimating the length of two-armed randomized survival trials using a survival density that allows for cure Sposto, Richard
1984
5 3 p. 303-
1 p.
artikel
40 Ethical and design considerations in a randomized trial of the effect of steroid vs. placebo therapy in severe sepsis Peduzzi, Peter
1984
5 3 p. 293-294
2 p.
artikel
41 Factorial designs for randomized trials Byar, David P.
1984
5 3 p. 296-
1 p.
artikel
42 Fifth annual meeting Society for clinical trials 1984
5 3 p. 279-290
12 p.
artikel
43 Fully informed consent: The diabetes control and complications trial approach to the informed consent process 1984
5 3 p. 293-
1 p.
artikel
44 Generalized data management systems: Report on operational experiences Singer, Stephen W.
1984
5 3 p. 303-
1 p.
artikel
45 Graphic formats to display trends in adherence behavior changes Newman, Barbara
1984
5 3 p. 311-
1 p.
artikel
46 Handling of patient dropouts in trials measuring long-term survival Bhaskar, R.
1984
5 3 p. 306-
1 p.
artikel
47 Judgment analysis in clinical trials: How to save the baby from the bathwater Joyce, C.R.B.
1984
5 3 p. 307-308
2 p.
artikel
48 Logistical considerations industries face in initiating a large-scale clinical trial Kirkham, D.
1984
5 3 p. 310-
1 p.
artikel
49 Logistics of double-blinding a randomized trial of intravenous vs. subcutaneous heparin for the treatment of venous thrombosis Raskob, G.
1984
5 3 p. 300-
1 p.
artikel
50 Longitudinal measures of compliance in the elderly Greenlick, Merwyn
1984
5 3 p. 313-
1 p.
artikel
51 Mammographic quality control in the Canadian national breast screening study (NBSS) Baines, Cornelia J.
1984
5 3 p. 295-
1 p.
artikel
52 Measuring functional outcomes in therapeutic trials for chronic disease Deyo, Richard A.
1984
5 3 p. 223-240
18 p.
artikel
53 Methodological considerations of withdrawal studies Friedman, Lawrence
1984
5 3 p. 296-
1 p.
artikel
54 Monitoring data logistics with a PC Herson, Jay
1984
5 3 p. 308-
1 p.
artikel
55 Multiple comparisons in clinical trials: How far should we go? Egger, Marlene J.
1984
5 3 p. 307-
1 p.
artikel
56 Multivariate bioassay Laska, Eugene M.
1984
5 3 p. 302-
1 p.
artikel
57 National Institutes of Health inventory of clinical trials Jacoby, Itzhak
1984
5 3 p. 298-
1 p.
artikel
58 Nonparametric procedures for comparing diagnostic tests with paired data Wieand, Samuel
1984
5 3 p. 303-
1 p.
artikel
59 Nurse practitioners in research: Untapped potential Hansen, Betty
1984
5 3 p. 294-
1 p.
artikel
60 Obtaining informed consent: Comparison of conventional and nonconventional methods Stoy, D.
1984
5 3 p. 293-
1 p.
artikel
61 On-site clinical trial data entry and check Gabrieli, Christopher F.O.
1984
5 3 p. 304-
1 p.
artikel
62 PIGAS, an interactive system for data management and data analysis of clinical trials Jan, P.
1984
5 3 p. 304-
1 p.
artikel
63 Planning, conducting and evaluating multicenter clinical trials in Germany— The view of a biometric center Koepcke, Wolfgang
1984
5 3 p. 298-
1 p.
artikel
64 Pooling trial results Jesdinsky, Hans J.
1984
5 3 p. 307-
1 p.
artikel
65 Program on the surgical control of the hyperlipidemias (POSCH): Variability in lesion assessment in single and serial paired coronary arteriograms Fitch, Laurie L.
1984
5 3 p. 291-
1 p.
artikel
66 Quality control in postmarketing epidemiologic studies Luscombe, F.A.
1984
5 3 p. 312-
1 p.
artikel
67 Rapid safety monitoring in phase I clinical trials of new antiepileptic drugs via a computer-based method Valakas, Antonia M.
1984
5 3 p. 312-
1 p.
artikel
68 Sample size and duration of follow-up for stratified clinical trials Bauer, Madeline
1984
5 3 p. 305-
1 p.
artikel
69 Selection of adequate response variables and their evaluation in rheumatology trials Zwingers, Thomas
1984
5 3 p. 295-296
2 p.
artikel
70 Site visits in a multicenter ophthalmic clinical trial Cassel, Gary H.
1984
5 3 p. 251-262
12 p.
artikel
71 Sponsor dos and don'ts—The MIAMI lesson Lorstad, Mats H.
1984
5 3 p. 298-
1 p.
artikel
72 Statistics in practice Buyse, Marc
1984
5 3 p. 315-316
2 p.
artikel
73 Success in changing established medication dosing schedules in a clinical trial Probstfield, Jeffrey L.
1984
5 3 p. 306-
1 p.
artikel
74 Table-driven identification checks in multicenter clinical trials—principles and implementation Alamercery, Y.
1984
5 3 p. 310-
1 p.
artikel
75 Testing hypotheses in clinical trials Lynch, Cornelius J.
1984
5 3 p. 301-
1 p.
artikel
76 The clinical trial outline Leon, Judith M.
1984
5 3 p. 311-
1 p.
artikel
77 The compassionate use protocol as a reseach tool Rodel, Philip V.
1984
5 3 p. 310-
1 p.
artikel
78 The effect of varying the number of response categories in a likert-type scale on response rate Birkett, Nicholas John
1984
5 3 p. 299-
1 p.
artikel
79 The impact of screening sensitivity on sample size requirements for cancer prevention trials Patterson, Blossom H.
1984
5 3 p. 305-306
2 p.
artikel
80 The importance of (A) rapid data processing and (B) randomization in phase II trials of cytotoxics in oncology illustrated by the trials of an analogue of cisplatin P. A'Hern, Roger
1984
5 3 p. 302-
1 p.
artikel
81 The prism adaptation trial design: A two-level randomization scheme to address three questions Connett, John E.
1984
5 3 p. 299-
1 p.
artikel
82 The program on the surgical control of the hyperlipidemias: Final sample size Matts, John
1984
5 3 p. 295-
1 p.
artikel
83 The use of one-sided tests of significance in clinical trials Lan, K.K.Gordon
1984
5 3 p. 299-
1 p.
artikel
84 Ticlopidine aspirin stroke study Kamm, Barbara
1984
5 3 p. 298-
1 p.
artikel
85 Unblinding and debriefing participants in a clinical trial Southam, Mary A.
1984
5 3 p. 311-312
2 p.
artikel
86 Use of the logistic model in the design of intervention studies Neaton, James D.
1984
5 3 p. 297-
1 p.
artikel
87 Using case-control data to estimate sample sizes required for disease prevention trials in high-risk groups Green, Sylvan B.
1984
5 3 p. 305-
1 p.
artikel
88 Using clinical opinion in the design of fixed-sized trials Freedman, Laurence S.
1984
5 3 p. 302-
1 p.
artikel
89 Verification of prognastic factors in multicenter clinical trials Diener, M.D.
1984
5 3 p. 309-
1 p.
artikel
90 Veterans administration cooperative study of disulfiram in the treatment of alcoholism: Study design and methodological considerations Fuller, Richard K.
1984
5 3 p. 263-273
11 p.
artikel
91 What happens to study dropouts? Cramer, Joyce A.
1984
5 3 p. 307-
1 p.
artikel
92 Who should code cause of death in a clinical trial? Remington, Richard D.
1984
5 3 p. 241-244
4 p.
artikel
                             92 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland